Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 84pembrolizumab 69Pemetrexed 62Cisplatin 52Paclitaxel 30Docetaxel 29atezolizumab 28durvalumab 25Specimen Handling 25Nivolumab 24Magnetic Resonance Spectroscopy 20osimertinib 18Gemcitabine 18130-nm albumin-bound paclitaxel 18Etoposide 16Cetuximab 14Radiotherapy 13Platinum 12Taxes 10Immunoglobulin G 101,2-diaminocyclohexaneplatinum II citrate 10Disulfides 9Bevacizumab 9amivantamab 8Topotecan 8Radiation 8Ipilimumab 8fludarabine 7Ramucirumab 7PM 01183 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Receptors, Vascular Endothelial Growth Factor × Thoracic × 30 days × Clear all
NCT04777994 2026-06-04

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Calico Life Sciences LLC

Phase 1 Recruiting
248 enrolled
GenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡